The Department of Health and Human Services recently made a big announcement. They said that hormone replacement therapy (HRT) would no longer carry a severe warning. This warning had suggested that HRT could cause cancer and stroke. The FDA decided to remove this warning, saying it was based on out
A big recall is underway for ByHeart's organic baby formula. This comes after a number of babies got sick with infant botulism. The recall now covers all of their products, not just a few batches. Fifteen babies in twelve states have fallen ill since August. All of them were given ByHeart formula.
The U. S. Food and Drug Administration is looking to bring in a new boss for its drug approval team. This person, Richard Pazdur, is known for his work in cancer treatments. If he takes the job, he'll be in charge of making sure most medicines, from those you buy without a prescription to those need
Menopause can be a challenging phase, with symptoms like hot flashes, night sweats, and sleep disturbances. Recent updates from the FDA have made hormone therapy more accessible by removing some of the previously alarming warning labels. This shift is based on new research indicating that hormone th
The FDA has decided to take off the strong warning labels from hormone-based menopause treatments. These treatments help with hot flashes and night sweats. The warning labels talked about serious risks like stroke, heart attacks, and dementia. This change is based on new studies. They show that hor
The FDA has made a big change. They are asking drug companies to remove the strongest warnings from menopause hormone treatments. These warnings, called "black box" warnings, alert users to serious risks. The FDA looked at lots of studies and got advice from experts before making this decision. The
In 2025, a significant update was made to how doctors treat a liver condition called MASH. This condition is linked to metabolic issues and used to be known as NAFLD. The update focuses on using a drug called semaglutide, which is found in a medication named Wegovy. The FDA gave Wegovy the green li
Dr. George Tidmarsh, the head of the FDA's drug evaluation center, is currently on leave and might quit. Why? He says the workplace is "toxic" and unfair. The FDA says they put him on leave because of concerns about his behavior. Some reports say Tidmarsh used his power to hurt a business partner.
The Food and Drug Administration's drug division is in chaos. Dr. George Tidmarsh, who leads this division, is on leave. He says it's because he spoke up about a new program. This program fast-tracks some drug approvals. He thinks it's not based on solid science. Instead, he believes politics are pl
The FDA has recently taken a stand against unapproved fluoride drugs for children, highlighting potential health risks. This move targets products that have been on the market for years, often promoted as a way to prevent tooth decay. The FDA sent notices to four companies selling these products, es
